Back to top
more

Boston Scientific (BSX)

(Real Time Quote from BATS)

$72.86 USD

72.86
740,350

-0.31 (-0.42%)

Updated Apr 29, 2024 10:34 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (142 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

Headquartered in Natick, MA and founded in 1979, Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments viz. Cardiovascular (39.6% of total revenue in 2019; up 10% organically from 2018), Rhythm and Neuro (28.1%; up 1%) and MedSurg (30.2%; up 10.6%).

PBH or BSX: Which Is the Better Value Stock Right Now?

PBH vs. BSX: Which Stock Is the Better Value Option?

What's in Store for Boston Scientific (BSX) in Q4 Earnings?

Boston Scientific (BSX) is expected to have witnessed strong growth of the WATCHMAN franchise in the fourth quarter, given the FDA approval of WATCHMAN FLX Pro in September.

Boston Scientific (BSX) Rides on Global Growth Amid Macro Woes

Within APAC, Boston Scientific (BSX) is registering strong growth in Japan and China.

Here's How Much You'd Have If You Invested $1000 in Boston Scientific a Decade Ago

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Boston Scientific (BSX) Initiates AVANT GUARD Clinical Trial

Boston Scientific's (BSX) AVANT GUARD clinical trial is set to evaluate the FARAPULSE PFA System as the first-line treatment for persistent AF.

PBH vs. BSX: Which Stock Is the Better Value Option?

PBH vs. BSX: Which Stock Is the Better Value Option?

PBH or BSX: Which Is the Better Value Stock Right Now?

PBH vs. BSX: Which Stock Is the Better Value Option?

Boston Scientific (BSX) Hits 52-Week High: What's Aiding It?

Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment.

Here's Why You Should Retain Boston Scientific (BSX) Now

Investors are optimistic about Boston Scientific (BSX) on strong worldwide demand for its GI and pulmonary treatment options and traction in Europe for its next-generation WATCHMAN FLX.

Perrigo (PRGO) Up 2% Since Last Earnings Report: Can It Continue?

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Boston Scientific (BSX) Gains From Global Expansion, FX Woe Ails

Boston Scientific's (BSX) Endoscopy business within MedSurg benefits from strong worldwide demand for its broad range of GI and pulmonary treatment options.

If You Invested $1000 in Boston Scientific 10 Years Ago, This Is How Much You'd Have Now

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

PBH or BSX: Which Is the Better Value Stock Right Now?

PBH vs. BSX: Which Stock Is the Better Value Option?

Boston Scientific (BSX) Closes the Relievant Medsystems Buyout

Boston Scientific (BSX) expands the neuromodulation portfolio with the acquisition of Relievant Medsystems.

Boston Scientific (BSX) Just Reclaimed the 50-Day Moving Average

Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?

PBH vs. BSX: Which Stock Is the Better Value Option?

PBH vs. BSX: Which Stock Is the Better Value Option?

If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Here's Why You Should Retain Boston Scientific (BSX) Now

Investors are optimistic about Boston Scientific (BSX), led by growing demand for WATCHMAN FLX devices and upbeat guidance.

Sheraz Mian headshot

Top Stock Reports for Microsoft, NIKE & BP

Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), NIKE, Inc. (NKE) and BP p.l.c. (BP).

PacBio (PACB) Tops on Q3 Earnings, Raises FY23 Revenue View

PacBio (PACB) witnesses strong revenue growth in the third quarter, partly aided by customers' continued product transition to the Revio system.

Ecolab (ECL) Q3 Earnings Surpass Estimates, Margins Rise

Ecolab's (ECL) robust performance across all segments drives its third-quarter sales despite business challenges.

Avantor (AVTR) Q3 Earnings In-Line With Estimates, Revenues Top

Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft third-quarter performance.

Revvity (RVTY) Misses on Q3 Earnings, Lowers '23 EPS View

Revvity's (RVTY) third-quarter results reflect the impact of increased market uncertainty. The company's earnings and sales miss their respective estimates.

Are Medical Stocks Lagging Boston Scientific (BSX) This Year?

Here is how Boston Scientific (BSX) and Adagene Inc. Sponsored ADR (ADAG) have performed compared to their sector so far this year.

Integer Holdings (ITGR) Q3 Earnings Top Estimates, FY23 View Up

Integer Holdings' (ITGR) third-quarter results reflect robust Medical Sales, along with strength in the majority of the product lines.